Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001144204-08-033296

10% owner bought 70,000 shares at an average $4.28 ($299,751)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trinad Capital Master Fund Ltd. 10% owner 2008-05-30 Purchase +35,000 $4.56 $159,751 2,213,170 D
Trinad Capital Master Fund Ltd. 10% owner 2008-06-02 Purchase +35,000 $4.00 $140,000 2,248,170 D
Open-market purchases · 70,000 sh · avg $4.28 · $299,751
Loading xslF345X02/v116422_ex.xml…